Skip to main content
. 2013 Aug 2;31(35):3469–3472. doi: 10.1016/j.vaccine.2013.04.062

Table 1.

BAL levels of total IgG, anti-pneumococcal specific IgG and ratios of pneumococcal specific IgG: total IgG in HIV-infected and control groups.

HIV-infected Control p-Value
Total IgG 13,404 (6985, 19,823) 4400 (3254, 5546) 0.003a
Anti-Ply IgG 9.83 (2.70, 16.97) 2.19 (1.40, 2.97) 0.02a
Anti-Ply:total IgG ratio 0.18 (0.13, 0.23) 0.05 (0.01, 0.09) 0.0002a
Anti-PspA IgG 45.66 (17.99, 73.34) 11.82 (8.49, 15.14) 0.01a
Anti-PspA:total IgG ratio 0.36 (0.31, 0.41) 0.27 (0.24, 0.30) 0.001a

Values are mean ± 95% confidence intervals and ratios of pneumococcal specific IgG:total IgG.

a

Using unpaired students’ t-test, p ≤ 0.05 when comparing HIV-infected and control groups.